Marvell Technology (MRVL) has run up this week, including a more than 6% pop today. Yesterday, the company announced its first significant layoffs in years, cutting 320 jobs, or 4% of its workforce. The layoffs impacted the company’s entire R&D team in China and a few U.S. jobs. Wall Street cheered the move to improve…
I am recommending we roll our Marvell Technology (MRVL) put out two weeks to generate more income and reduce our net debit on this core position. You can enter the second leg of today’s trade even if you were not in the previous one. Just be aware that we will be managing and tracking…
I am recommending we sell a put on Marvell Technology (MRVL) to reduce our net debit on the position. The stock sold off as much as 11% on Friday following the release of the company’s fourth-quarter and full-year results before closing the day down around 5%. Q4 revenue of $1.42 billion was up 6% year…
With Marvell Technology (MRVL) scheduled to announce fourth-quarter and full-year results tomorrow, I am recommending we buy back the put we sold to avoid earnings risk. If the chipmaker reports strong results and a bullish forecast for 2023, I will recommend a new put to sell for income. If not, I am inclined to book…
We temporarily exited our Devon Energy (DVN) position by selling our shares to avoid the company’s earnings announcement. The stock sold off 17% last week after the fracker reported disappointing fourth-quarter results and has continued to drift. Devon’s adjusted fourth-quarter earnings of $1.66 per share declined from a year ago and missed the consensus analyst…
Marvell Technology (MRVL) is selling off today, but our MRVL Feb Monthly (2/17) 39 Call remains deep in the money. I am recommending we allow our shares to be called away, incurring a large net debit. I will recommend a put to sell soon to generate income and reduce that net debit. However, we will…
I am recommending we roll our Marvell Technology (MRVL) call out three weeks and to a higher strike price to avoid having our shares called away. While we will need to spend a bit of cash to roll, we are picking up another $1 in potential capital appreciation. Current Stock Price: $43.52 Cost Basis: $55.80…
I am recommending we roll our Marvell Technology (MRVL) and Pfizer (PFE) calls out two weeks to generate more cash and reduce our cost basis on the positions. MRVL has outperformed the broader market over the past week. We are rolling our call up to capture more potential appreciation in shares in addition to income.…
I am recommending we sell calls on our uncovered Marvell Technology (MRVL) and Pfizer (PFE) shares to generate income and reduce our cost basis on the positions. You can enter today’s trades even if you were not in the previous positions. Just be sure to purchase 100 shares of the underlying stocks first for every…
Bank of America (BAC) is trending in the right direction, but this has pushed our call in the money. With the bank set to report earnings next week, I am recommending we allow our shares to be called away. Once we see how the market responds to the announcement, we will sell a put to…
